New methodology for improved tissue analysis and in vitro diagnosis
| Reference number | |
| Coordinator | MEDETECT AB - MEDETECT AB, Lund |
| Funding from Vinnova | SEK 2 586 000 |
| Project duration | June 2014 - December 2015 |
| Status | Completed |
Purpose and goal
The technical development and conceptual testing of the AMLC technology has been achieved with very good results. Software extensions for the application of more advanced statistics and sub-cellular analysis have been added. The technology can now be used for generation of complex tissue images and ´histomic´ data. A module with more advanced data mining features is still under construction. The diagnostic potential in breast cancer will be investigated in cooperation with Lund University and University Hospital in a separate Swelife project.
Results and expected effects
The concept tests have resulted in very good results and also highlighted the added scientific value of the generated ´histomic data´, something that also sparked a lot of national and international interest. The technology is now provided as CRO-service and as a powerful analysis tool in collaboration projects with the pharmaceutical industry and academia. For Medetect this has led to a company market growth within the area of advanced tissue analysis.
Approach and implementation
The support from Vinnova has been an important and necessary catalyst for early introduction of the AMLC-technology into the CRO market. The project has in all essential parts progressed according to plan and is now well equipped for future expansion.